IP Expertise: A commercial and legal assessment of your registered and unregistered IP rights
Combining IP expertise and commercial acumen
Our expertise includes IP valuation, IP audits, freedom to operate and patent landscape analysis across all technology sectors and encompassing both registered and unregistered IP rights. Our team includes qualified IP professionals as well as professionals with first-hand industry and commercial knowledge across a wide range of technology and commercial sectors.
Supporting commercial decisions
Our IP expertise supports clients with investment, fund raising, technology in- and out-licensing and corporate restructuring decisions.
We use industry leading patent databases and analytical tools including tools for patent landscaping. Along with these tools we have developed a number of proprietary IP auditing assessment tools and IP valuation models which our clients benefit from. We are experienced with valuing all forms of IP using conventional cost based, income based and comparator based approaches. Our IP analytics are informed by our wider commercial knowledge across different industries to give pragmatic advice to clients set against their commercial context.
The white paper focuses on three areas: Animal Product Replacements, Alternative Protein Sources and Future Farming Technologies.
- Providing a comprehensive valuation of a multi-million pound annual royalty stream due to a UK-based research organisation arising from sales of a blockbuster drug by their licensee. The purpose of the valuation was to help inform the organisation in its subsequent successful negotiations to monetise part of this royalty stream.
- Providing a patent landscape for a UK research institute as part of an overall market assessment investigating the opportunity to produce omega-3 fish oils in genetically modified plants leading to the institute securing significant additional translational funding to undertake field trails and industry testing of the resulting oil product.
- Undertaking IP valuations for a meningitis B vaccine clinical phase candidate and a respiratory syncytial virus pre-clinical vaccine candidate for a Dutch government institute, including providing business development support to help the client complete a major joint development and licensing agreement.